Literature DB >> 11402295

Protein transduction: an alternative to genetic intervention?

K G Ford1, B E Souberbielle, D Darling, F Farzaneh.   

Abstract

Protein transduction, an emerging technology with potential applications in gene therapy, can best be described as the internalisation of proteins into the cell, from the external environment. This process relies on the inherent property of a small number of proteins and peptides of being able to penetrate the cell membrane. The transducing property of these molecules can be conferred upon proteins which are expressed as fusions with them and thus offers an alternative to gene therapy for the delivery of therapeutic proteins into target cells. This review describes the three most commonly used protein transduction vehicles; the antennapedia peptide, the herpes simplex virus VP22 protein and HIV TAT protein transduction domain. The future prospects for the application of this technology in gene therapy are also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402295     DOI: 10.1038/sj.gt.3301383

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  25 in total

1.  Adenovirus dodecahedron allows large multimeric protein transduction in human cells.

Authors:  P Fender; G Schoehn; J Foucaud-Gamen; E Gout; A Garcel; E Drouet; J Chroboczek
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Protein transduction from retroviral Gag precursors.

Authors:  Christine Voelkel; Melanie Galla; Tobias Maetzig; Eva Warlich; Johannes Kuehle; Daniela Zychlinski; Juergen Bode; Tobias Cantz; Axel Schambach; Christopher Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 3.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

4.  Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model.

Authors:  Florian Graepler; Marie-Luise Lemken; Wolfgang A Wybranietz; Ulrike Schmidt; Irina Smirnow; Christine D Gross; Martin Spiegel; Andrea Schenk; Hansjörg Graf; Ulrike A Lauer; Reinhard Vonthein; Michael Gregor; Sorin Armeanu; Michael Bitzer; Ulrich M Lauer
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 5.  Gold nanoparticles: From nanomedicine to nanosensing.

Authors:  Po C Chen; Sandra C Mwakwari; Adegboyega K Oyelere
Journal:  Nanotechnol Sci Appl       Date:  2008-11-02

Review 6.  Progress and promise towards safe induced pluripotent stem cells for therapy.

Authors:  Ali Seifinejad; Mohammadsharif Tabebordbar; Hossein Baharvand; Laurie A Boyer; Ghasem Hosseini Salekdeh
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

7.  Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response.

Authors:  H Naora; F J Montz; C Y Chai; R B Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

8.  Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles.

Authors:  Yang Liu; Hao Wang; Ken-ichiro Kamei; Ming Yan; Kuan-Ju Chen; Qinghua Yuan; Linqi Shi; Yunfeng Lu; Hsian-Rong Tseng
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-02       Impact factor: 15.336

9.  Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

Authors:  Amit Choudhury; Michel Dominguez; Vishwajeet Puri; Deepak K Sharma; Keishi Narita; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 10.  Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling.

Authors:  Claudia Buerger; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-11       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.